In addition, GLP-1 inhibits glucagon release (which slows down the release of sugar into the blood so that you burn more fat), slows down gastric emptying (makes you feel full), and lowers the desire for food intake (because you feel full)
Theres also a version of this where GLP-1 drugs, at the right dose, for the right person, at the right time, turn out to be genuinely useful for chronic pain
The percentage of patients who discontinued due to ineffective therapy was 3.0% in the liraglutide injection 1.8 mg + glimepiride treatment group, 3.5% in the liraglutide injection 1.2 mg + glimepiride treatment group, 17.5% in the placebo + glimepiride treatment group, and 6.9% in the rosiglitazone + glimepiride treatment group
Br J Pharmacol 179(4):492510
Effectiveness : Bariatric surgery can result in 2030% weight loss, while Semaglutide averages 15%a comparable outcome without surgery